440 related articles for article (PubMed ID: 28889317)
1. The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus.
Craven CL; Baudracco I; Zetterberg H; Lunn MPT; Chapman MD; Lakdawala N; Watkins LD; Toma AK
Acta Neurochir (Wien); 2017 Dec; 159(12):2293-2300. PubMed ID: 28889317
[TBL] [Abstract][Full Text] [Related]
2. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
[TBL] [Abstract][Full Text] [Related]
3. Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus.
Braun M; Bjurnemark C; Seo W; Freyhult E; Nyholm D; Niemelä V; Blennow K; Zetterberg H; Fällmar D; Kultima K; Virhammar J
Fluids Barriers CNS; 2022 Feb; 19(1):15. PubMed ID: 35164790
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid and venous biomarkers of shunt-responsive idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis.
Thavarajasingam SG; El-Khatib M; Vemulapalli KV; Iradukunda HAS; Laleye J; Russo S; Eichhorn C; Eide PK
Acta Neurochir (Wien); 2022 Jul; 164(7):1719-1746. PubMed ID: 35230552
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A
J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256
[TBL] [Abstract][Full Text] [Related]
6. P-Tau as prognostic marker in long term follow up for patients with shunted iNPH.
Migliorati K; Panciani PP; Pertichetti M; Borroni B; Archetti S; Rozzini L; Padovani A; Terzi L; Bruscella S; Fontanella MM
Neurol Res; 2021 Jan; 43(1):78-85. PubMed ID: 33059546
[No Abstract] [Full Text] [Related]
7. Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus.
Kazui H; Kanemoto H; Yoshiyama K; Kishima H; Suzuki Y; Sato S; Suehiro T; Azuma S; Yoshimine T; Tanaka T
J Neurol Sci; 2016 Oct; 369():236-241. PubMed ID: 27653897
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y
Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
Kang K; Ko PW; Jin M; Suk K; Lee HW
J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus.
Nakajima M; Miyajima M; Ogino I; Akiba C; Sugano H; Hara T; Fusegi K; Karagiozov K; Arai H
J Neurol Sci; 2015 Oct; 357(1-2):88-95. PubMed ID: 26169158
[TBL] [Abstract][Full Text] [Related]
11. Cerebral blood flow and Alzheimer's disease-related biomarkers in cerebrospinal fluid in idiopathic normal pressure hydrocephalus.
Azuma S; Kazui H; Kanemoto H; Suzuki Y; Sato S; Suehiro T; Matsumoto T; Yoshiyama K; Kishima H; Shimosegawa E; Tanaka T; Ikeda M
Psychogeriatrics; 2019 Nov; 19(6):527-538. PubMed ID: 30916850
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.
Abu-Rumeileh S; Giannini G; Polischi B; Albini-Riccioli L; Milletti D; Oppi F; Stanzani-Maserati M; Capellari S; Mantovani P; Palandri G; Cortelli P; Cevoli S; Parchi P
J Alzheimers Dis; 2019; 68(2):723-733. PubMed ID: 30883350
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
Manniche C; Hejl AM; Hasselbalch SG; Simonsen AH
J Alzheimers Dis; 2019; 68(1):267-279. PubMed ID: 30741681
[TBL] [Abstract][Full Text] [Related]
14. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
Jeppsson A; Wikkelsö C; Blennow K; Zetterberg H; Constantinescu R; Remes AM; Herukka SK; Rauramaa T; Nagga K; Leinonen V; Tullberg M
J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1117-1123. PubMed ID: 31167811
[TBL] [Abstract][Full Text] [Related]
15. Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
Jingami N; Uemura K; Asada-Utsugi M; Kuzuya A; Yamada S; Ishikawa M; Kawahara T; Iwasaki T; Atsuchi M; Takahashi R; Kinoshita A
J Alzheimers Dis; 2019; 72(1):271-277. PubMed ID: 31561378
[TBL] [Abstract][Full Text] [Related]
16. Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus.
Yang F; Yang L; Fang X; Deng Y; Mao R; Yan A; Wei W
J Alzheimers Dis; 2023; 93(4):1341-1354. PubMed ID: 37182875
[TBL] [Abstract][Full Text] [Related]
17. Neuronal pentraxin 2 correlates with neurodegeneration but not cognition in idiopathic normal pressure hydrocephalus (iNPH).
Patel M; Zhang Y; Xiao MF; Worley P; Moghekar A
Neurol Neurochir Pol; 2024; 58(1):47-53. PubMed ID: 38393959
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease.
Manniche C; Simonsen AH; Hasselbalch SG; Andreasson U; Zetterberg H; Blennow K; Høgh P; Juhler M; Hejl AM
J Alzheimers Dis; 2020; 75(3):937-947. PubMed ID: 32390628
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus.
Nakajima M; Miyajima M; Ogino I; Akiba C; Kawamura K; Kamohara C; Fusegi K; Harada Y; Hara T; Sugano H; Tange Y; Karagiozov K; Kasuga K; Ikeuchi T; Tokuda T; Arai H
J Alzheimers Dis; 2018; 66(1):319-331. PubMed ID: 30248058
[TBL] [Abstract][Full Text] [Related]
20. A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias.
Said HM; Kaya D; Yavuz I; Dost FS; Altun ZS; Isik AT
Clin Interv Aging; 2022; 17():467-477. PubMed ID: 35431542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
